ArticleInternational journal of hematology2022
NK-cell post-transplant lymphoproliferative disease successfully treated by second allogenic hematopoietic stem cell transplantation in chronic active Epstein-Barr virus infection.
Sho Shibata et al.PubMed ↗Publisher ↗
No numbers read from the abstract.